Prednisolone enhancement of primary endocrine anticancer treatment: a possible anti-angiogenic effect
1989
Prednisolone and Anti-Angiogenesis in Cancer Treatment
Editorial
Author Information
Author(s): J.T. Beranek
Primary Institution: Service d'Anatomie et Cytologie Pathologiques, Groupe Hospitalier Pitie-Salpetriere
Hypothesis
Corticosteroids may have an anti-angiogenic effect in cancer treatment.
Conclusion
Corticosteroids like prednisolone could potentially enhance cancer treatment by reducing blood vessel growth in tumors.
Supporting Evidence
- Corticosteroids have shown anti-angiogenic effects in vitro.
- Malignant tumors depend on angiogenesis for growth.
- Long-term use of corticosteroids may lead to cumulative effects.
Takeaway
Prednisolone might help fight cancer by stopping tumors from growing new blood vessels.
Limitations
The effectiveness of prednisolone for anti-angiogenesis is uncertain due to low doses used in studies.
Want to read the original?
Access the complete publication on the publisher's website